| Alzheimer’s disease (AD) |
| Intravenous (IV) |
| AMP-activated protein kinase (AMPK) |
| Amyloid precursor protein (APP) |
| Amyloid-beta (Aβ) |
| Analysis of Variance (ANOVA) |
| Citrate synthase (CS) |
| Cytochrome c oxidase (COX) |
| Discosoma sp. red fluorescent protein (DsRed) |
| Familial Alzheimer’s disease (FAD) |
| Five FAD mutations (5XFAD mice) |
| Fluoro-Jade C (FJC) |
| Gamma-Aminobutyric Acid (GABA) |
| Gene Ontology enRIchment anaLysis analysis and visuaLizAtion tool (GOrilla) |
| Gene Ontology Term Enrichment (GOTERM) |
| Histone deacetylase (HDAC) |
| In vivo imaging system (IVIS) |
| Insulin-like growth factor-binding protein (Igfbp) |
| Intracerebroventricular (ICV) |
| Kyoto Encyclopedia of Genes and Genomes (KEGG) |
| Label-free quantitation (LFQ) |
| Least significant difference (LSD) |
| Liquid chromatography-tandem mass spectrometry (LC-MSMS) |
| Neuronal nuclei (NeuN) |
| Partial least square discriminant analysis (PLS-DA) |
| Peroxisome proliferator-activated receptor (PPAR) |
| Phosphoinositide 3-kinase (PI3K) |
| Post-synaptic density (PSD) |
| Post-translational modification (PTM) |
| Presenilin1 (PS1) |
| Red fluorescent protein (RFP) |
| The Small Molecule Pathway Database (SMPDB) |
| Transgenic (Tg) |
| Vascular endothelial growth factor (VEGF) |
| VIP (measure of a variable’s importance) |
| Full names of proteins are presented in the Supplemental-proteomics-excels |